NasdaqGS:XRAYMedical Equipment
Is Weak Revenue And ROIC Undermining The Investment Case For DENTSPLY SIRONA (XRAY)?
In recent months, Dentsply Sirona reported softer quarterly results alongside a two-year decline in constant-currency revenue and weakening return on invested capital, raising questions about the effectiveness of its recent investments.
This combination of shrinking underlying sales and negative returns on new capital suggests the company is struggling to turn portfolio spending into profitable growth.
Next, we'll examine how these disappointing quarterly results and deteriorating return on...